← Back to Patent Explorer
US5783633A Expired / Lapsed US ⏱️ 0.0 years remaining

Bicompatible polyisoprene-polyurethane interpenetrating polymer network compositions and medical devices made therefrom

Assignee: Boston Scientific Scimed Inc
•
Filing: 1997-06-18
•
Granted: 1998-07-21
•
Expires: 2017-06-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Interpenetrating polymer networks (IPN's), composed of polyisoprene (PI) and polyurethane (PU), together with a process for their preparation and their use in the manufacture of medical devices, such as catheters and catheter balloons, are disclosed. Both components are elastomers. The PI component is chemically crosslinked. The PU component is crystallizable and contains only physical crosslinks. The IPN's have glass transition temperatures in the range of from -65 DEG C. to -40 DEG C.

Inventors

  • 👤 Leslie H. Sperling
  • 👤 Clarence J. Murphy
  • 👤 Vinay Mishra

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 19:30
CPC Classifications
C; C08; C08L; C08L9/00; A; A61; A61L; A61L29/00; A61L29/04; A61L29/049; C08L75/00; C08L75/04; C08L75/08; C08G; C08G2250/00; C08G2270/00; C08L2203/00; C08L2203/02; C08L2205/00; C08L2205/04; Y; Y10; Y10S; Y10S525/00; Y10S525/903

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 308 words
A medical device fabricated from a biocompatible material comprising a composition which is an elastomeric semi-interpenetrating polymer network composed of; a.) a medical grade of a crystalline, physically crosslinked polyurethane which contains polyether elastomeric blocks alternating with urethane linkages or polyester elastomeric blocks alternating with urethane linkages, said polyurethane having a variable amount of crystallinity, such that when said material is in a relaxed state, said polyurethane is not fully crystalline and contains at least some non-physically crosslinked non-crystalline regions, and such that when said material is in a stretched or extended state, said polyurethane is more crystalline than when said material is in said relaxed state, with said polyurethane then containing a greater number of physically crosslinked crystalline regions, and further such that said amount of crystallinity of said polyurethane is reversible as said material is alternated between said stretched or extended state and said relaxed state; and (b.) a medical grade of linear, crystalline, chemically crosslinked cis-1,4 polyisoprene, said cis-1.4 polyisoprene having a variable amount of crystallinity, such that when said material is in a relaxed state, said cis-1,4 polyisoprene is chemically crosslinked and is not some non-crystalline regions, and such that when said material is in a stretched or extended state, said cis-1,4 polyisoprene is chemically crosslinked and is more crystalline than when said material is in said relaxed state, with said cis-1,4 polyisoprene then containing a greater number of chemically crosslinked crystalline regions, and further such that said amount of crystallinity of said cis-l,4 polyisoprene is reversible as said material is alternated between said stretched or extended state and said relaxed state; wherein both said polyurethane and said cis-1,4 polyisoprene have morphologies such that they each exist in a co-continuous phase; and wherein said polyurethane and said cis-1,4 polyisoprene are present in a ratio of from about 1:99 to about 99:1, by weight, respectively.
Claim 2
Dependent Claim 308 words
A medical device fabricated from a biocompatible material comprising a composition which is an elastomeric semi-interpenetrating polymer network composed of; a.) a medical grade of a crystalline, physically crosslinked polyurethane which contains polyether elastomeric blocks alternating with urethane linkages or polyester elastomeric blocks alternating with urethane linkages, said polyurethane having a variable amount of crystallinity, such that when said material is in a relaxed state, said polyurethane is not fully crystalline and contains at least some non-physically crosslinked non-crystalline regions, and such that when said material is in a stretched or extended state, said polyurethane is more crystalline than when said material is in said relaxed state, with said polyurethane then containing a greater number of physically crosslinked crystalline regions, and further such that said amount of crystallinity of said polyurethane is reversible as said material is alternated between said stretched or extended state and said relaxed state; and (b.) a medical grade of linear, crystalline, chemically crosslinked cis-1,4 polyisoprene, said cis-1.4 polyisoprene having a variable amount of crystallinity, such that when said material is in a relaxed state, said cis-1,4 polyisoprene is chemically crosslinked and is not some non-crystalline regions, and such that when said material is in a stretched or extended state, said cis-1,4 polyisoprene is chemically crosslinked and is more crystalline than when said material is in said relaxed state, with said cis-1,4 polyisoprene then containing a greater number of chemically crosslinked crystalline regions, and further such that said amount of crystallinity of said cis-l,4 polyisoprene is reversible as said material is alternated between said stretched or extended state and said relaxed state; wherein both said polyurethane and said cis-1,4 polyisoprene have morphologies such that they each exist in a co-continuous phase; and wherein said polyurethane and said cis-1,4 polyisoprene are present in a ratio of from about 1:99 to about 99:1, by weight, respectively.
Claim 3
Dependent Claim 29 words
The medical device according to claim 1 wherein the ratio of cis-1,4 polyisoprene to polyurethane in the biocompatible material is from about 10:90 to about 40:60, by weight, respectively.
Claim 4
Dependent Claim 36 words
The medical device according to claim 1 wherein when said polyurethane contains polyether elastomeric blocks, said polyether elastomeric blocks are selected from the group consisting of polyethylene glycol polyether, polypropylene glycol polyether, and polytetramethylene glycol polyether.
Claim 5
Dependent Claim 11 words
The medical device according to claim 1 which is a catheter.
Claim 6
Dependent Claim 11 words
The medical device according to claim 1 which is a stent.
Claim 7
Dependent Claim 20 words
The medical device according to claim 1 wherein the biocompatible material is in the form of a sheet or film.
Claim 8
Dependent Claim 13 words
The medical device according to claim 1 which is an inflatable dilatation balloon.

References Cited (Backward Citations)

US3980595A Cited
US5162414A Cited
US5087514A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-07-20 2002-01-19 2002-07-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-07-20 2006-01-19 2006-07-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-07-20 2010-01-19 2010-07-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag